On July 31, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 30, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 29, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 28, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The FDA has set several fee rates for fiscal year 2026, effective Oct. 1, 2025, through Sept. 30, 2026, according to multiple Federal Registernotices.
The FDA is seeking public comments on information collections related to the following forms:
The FDA's Office of Import Operations, which is affiliated with the FDA's Office of Inspections and Investigations, is making "important" changes to its Nationalized Entry Review Program on Aug. 4, saying the changes will "revolutionize import operations" by using a technology-driven approach that will streamline operations.
On July 24, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 23, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 22, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of: